Who is sponsoring NCT05104307?

NCT05104307 is sponsored by Stephen Esper.

What drugs are being tested in NCT05104307?

Interventions in NCT05104307: Cardiac Performance System (CPS) Device.

What condition does NCT05104307 study?

NCT05104307 studies Heart Diseases.

Is NCT05104307 still recruiting?

NCT05104307 is currently completed. Last updated 6 May 2024.

Last reviewed 2024-05-06 · How we verify

NCT05104307

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Echocardiogram and Cardiac Performance System (CPS) Ejection Fraction Validation Study

Completed Last updated 6 May 2024

What this trial tests

trial testing Cardiac Performance System (CPS) Device in Heart Diseases in 79 participants. Completed in 2 January 2024.

Timeline

9 November 2021

Primary endpoint
2 January 2024

2 January 2024

Quick facts

Lead sponsor	Stephen Esper
Status	Completed
Study type	OBSERVATIONAL
Enrollment	79
Start date	9 November 2021
Primary completion	2 January 2024
Estimated completion	2 January 2024
Sites	1 location across United States

Drugs / interventions tested

Cardiac Performance System (CPS) Device

Conditions studied

Heart Diseases — all drugs for Heart Diseases →

Sponsor

Stephen Esper

Who can join

18 and older, any sex, with Heart Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Heart Diseases

Currently open trials in the same condition.

NCT07288216 — Transition to KPL-387 Monotherapy Dosing & Administration Study · Phase 2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
NCT06769880 — Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Fa · NA · recruiting

Other Stephen Esper trials

Trials by the same sponsor.

NCT02887820 — Evaluating the Use of Thromboelastography (TEG) in Patient's Requiring Extracorporeal Membrane Oxygenation (ECMO) · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05104307 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stephen Esper
Last refreshed: 6 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05104307.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing